Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensogram Technologies has developed and commercialized wearable biosensors for real-time remote and mobile vital sign monitoring. Their flagship product SensoSCAN enables continuous non-invasive measurement of blood pressure, heart rate, respiration rate, oxygen saturation and more. The company’s technology has been deployed for real-time mobile health applications but there are no clinical trial results as it focuses on device development rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensogram Technologies.